EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Tuo-Min-Ding-Chuan Decoction Alleviates Airway Inflammations in the Allergic Asthmatic Mice Model by Regulating TLR4-NLRP3 Pathway-Mediated Pyroptosis: A Network Pharmacology and Experimental Verification Study

Mingsheng Lyu iD, Jingbo Qin iD, Shuaiyang Huang, Dongmei Shao, Guirui Huang, Fan Yang iD, Xuefeng Gong iD, Shiyu Zhang, Zhijie Zhang, Ji Wang iD, Hongsheng Cui

Drug Design, Development and Therapy · 2023

DOI: 10.2147/dddt.s406483 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Mingsheng Lyu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center of Respiratory Disease, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Asthma, Drugs, Chinese Herbal. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tuo-Min-Ding-Chuan Decoction (TMDCD) is an effective traditional Chinese medicine (TCM) formula granule for allergic asthma (AA). Previous studies proved its effects on controlling airway inflammations, while the specific mechanism was not clear.

Methods

We conducted a network pharmacology study to explore the molecular mechanism of TMDCD against AA with the public databases of TCMSP. Then, HUB genes were screened with the STRING database. DAVID database performed GO annotation and KEGG functional enrichment analysis of HUB genes, and it was verified with molecular docking by Autodock. Then, we built a classic ovalbumin-induced allergic asthma mice model to explore the mechanism of anti-inflammation effects of TMDCD.

Results

In the network pharmacology study, we found out that the potential mechanism of TMDCD against AA might be related to NOD-like receptor (NLR) signaling pathway and Toll-like receptor (TLR) signaling pathway. In the experiment, TMDCD showed remarkable effects on alleviating airway inflammations, airway hyperresponsiveness (AHR), and airway remodeling in the asthmatic mice model. Further molecular biology and immunohistochemistry experiments suggested TMDCD could repress TLR4-NLRP3 pathway-mediated pyroptosis-related gene transcriptions to inhibit expressions of target proteins.

Conclusion

TMDCD could alleviate asthmatic mice model airway inflammations by regulating TLR4-NLRP3 pathway-mediated pyroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaDrugs, Chinese HerbalAnimalsMiceNLR Family, Pyrin Domain-Containing 3 ProteinToll-Like Receptor 4Molecular Docking SimulationNetwork PharmacologyPyroptosisDisease Models, AnimalInflammation

Stichwörter der Autor:innen

NLRP3TLR4Tuo-Min-Ding-Chuan Decoctionallergic asthmanetwork pharmacologypyroptosistraditional Chinese medicine

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinToll-Like Receptor 4Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Center of Respiratory Disease, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
  • Department of Respiratory, The Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
  • Department of Geratology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
  • Department of Infectious Disease, Shunyi Hospital, Beijing Hospital of Traditional Chinese Medicine, Beijing, People's Republic of China.
  • College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
  • National Institute of Traditional Chinese Medicine (TCM) Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China.

ORCID-Profile: Mingsheng Lyu, Jingbo Qin, Fan Yang, Xuefeng Gong, Ji Wang

Zitieren

APA

Lyu, M., Qin, J., Huang, S., Shao, D., Huang, G., Yang, F., Gong, X., Zhang, S., Zhang, Z., Wang, J., & Cui, H. (2023). Tuo-Min-Ding-Chuan Decoction Alleviates Airway Inflammations in the Allergic Asthmatic Mice Model by Regulating TLR4-NLRP3 Pathway-Mediated Pyroptosis: A Network Pharmacology and Experimental Verification Study. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s406483

Vancouver

Lyu M, Qin J, Huang S, Shao D, Huang G, Yang F, et al. Tuo-Min-Ding-Chuan Decoction Alleviates Airway Inflammations in the Allergic Asthmatic Mice Model by Regulating TLR4-NLRP3 Pathway-Mediated Pyroptosis: A Network Pharmacology and Experimental Verification Study. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s406483

BibTeX
@article{Lyu2023,
  author = {Lyu, Mingsheng and Qin, Jingbo and Huang, Shuaiyang and Shao, Dongmei and Huang, Guirui and Yang, Fan and Gong, Xuefeng and Zhang, Shiyu and Zhang, Zhijie and Wang, Ji and Cui, Hongsheng},
  title = {Tuo-Min-Ding-Chuan Decoction Alleviates Airway Inflammations in the Allergic Asthmatic Mice Model by Regulating TLR4-NLRP3 Pathway-Mediated Pyroptosis: A Network Pharmacology and Experimental Verification Study},
  journal = {Drug Design, Development and Therapy},
  year = {2023},
  doi = {10.2147/dddt.s406483}
}
Kostenlos starten →